PAPILLOMAVIRUSES: HPV AS THE ETIOLOGICAL FACTOR OF HEAD AND NECK CANCERS

Publications

Share / Export Citation / Email / Print / Text size:

Postępy Mikrobiologii - Advancements of Microbiology

Polish Society of Microbiologists

Subject: Microbiology

GET ALERTS

ISSN: 0079-4252
eISSN: 2545-3149

DESCRIPTION

20
Reader(s)
49
Visit(s)
0
Comment(s)
0
Share(s)

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue / page

Related articles

VOLUME 57 , ISSUE 1 (June 2018) > List of articles

PAPILLOMAVIRUSES: HPV AS THE ETIOLOGICAL FACTOR OF HEAD AND NECK CANCERS

Michał Wiciński, Kamil Leis * / Bartosz Malinowski / Mateusz Maciej Węclewicz / Elżbieta Grześk / Grzegorz Grześk

Keywords : HPV, papillomaviruses, head and neck cancers

Citation Information : Postępy Mikrobiologii - Advancements of Microbiology. Volume 57, Issue 1, Pages 33-40, DOI: https://doi.org/10.21307/PM-2018.57.1.033

License : (CC BY-NC-ND 4.0)

Published Online: 23-May-2019

ARTICLE

ABSTRACT

The HPV virus, belonging to papillomaviruses, causes genital, lung, head and neck cancers. It is currently estimated that there are 190 types of HPV. Over 700 million people worldwide are infected with the virus. In the United States, 14 million new infections occur every year. The most common HPV types responsible for carcinogenesis of head and neck areas are types 16 and 18. The virus infects human epithelial cells, for example during a sexual intercourse. Transmission from mother to child during birth is also possible. There is evidence linking HPV with laryngeal cancer, leukoplakia, tonsil cancer or Bowen’s disease. HPV vaccines are available to help prevent infection by certain types of the virus, e.g. 9-valent HPV vaccine called Gardasil-9.

Content not available PDF Share

FIGURES & TABLES

REFERENCES

1. Abramson A.L., Steinberg B.M., Winkler B.: Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope, 97, 678–685 (1987)

2. Ault K.A.: Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract. Infect. Dis. Obstet. Gynecol. 1–5 (2006)

3. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., zur Hausen H., de Villiers E.M.: Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology, 401, 70–79 (2010)

4. Bieniek A., Cisło M., Matusiak Ł., Woźniak Z., Maj J., Barancewicz-Łosek M., Szybejko-Machaj G.: Rak brodawkujący (carcinoma verrucosum) – przegląd objawów klinicznych i histologicznych. Post. Dermatol. Alergol. 23, 57–66 (2006)

5. Bodaghi S., Wood L.V., Roby G., Ryder C., Steinberg S.M., Zheng Z.M.: Could human papillomaviruses be spread through blood? J. Clin. Microbiol. 43, 5428–5434 (2005)

6. Broniarczyk J., Koczorowska M.M., Durzyńska J., Warowicka A., Goździcka-Józefiak A.: Struktura i właściwości wirusa brodawczaka ludzkiego. Biotechnol. 3, 126–145 (2010)

7. Brzeziński P.: Choroba Bowena leczona przez trzy lata jako kontaktowe zapalenie skóry. Forum Medycyny Rodzinnej, 5, 266–270 (2011)

8. Cantrell S.C., Reid H.H., Li G., Wei Q., Sturgis E.M., Ginsberg L.E.: Influence of Smoking History on Imaging Characteristics among HPV-Positive Oropharyngeal Cancer Patients: A Blinded Matched-Pair Analysis. J. Comput. Assist. Tomogr. 38, 667 (2014)

9. Centers for Disease Control and Prevention: Cdc.gov/ Hpv [23-03-2017]

10. Chicheł A., Skowronek J.: Współczesne leczenie raka skóry – dermatologia, chirurgia czy radioterapia? Contemp. Onkol. 9, 429–435 (2005)

11. Chouhy D., Bolatti E.M., Perez G.R., Giri, A.A.: Analysis of the genetic diversity and phylogenetic relationships of putative human papillomavirus types. J. Gen. Virol. 94, 2480–2488 (2013)

12. Cielińska M., Ścierski W., Sowa P., Lisowska G.: Brodawczak odwrócony – etiologia, epidemiologia, klasyfikacja. Otorynolaryngologia, 15, 80–86 (2016)

13. Corbitt G., Zarod A.P., Arrand J.R., Longson M., Farrington W.T.: Human papillomavirus (HPV) genotypes associated with laryngeal papilloma. J. Clin. Pathol. 41, 284–288 (1988)

14. de Villiers E.M.: Cross-roads in the classification of papillomaviruses. Virology, 445, 2–10 (2013)

15. Donne A.J., Clarke R.: Recurrent respiratory papillomatosis: an uncommon but potentially devastating effect of human papillomavirus in children, Int. J. STD AIDS, 21, 381–385 (2010)

16. Dunne E.F., Markowitz L.E., Saraiya M., Stokley S., Middleman A., Unger E.R., Wiliams A., Iskander J.: CDC grand rounds: reducing the burden of HPV-associated cancer and disease. MMWR Morb. Mortal. Wkly. Rep. 63, 69–72 (2014)

17. Eriksen J.G., Lassen P., Overgaard J.: Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab? Lancet Oncol. 11, 312–313 (2010)

18. Fakhry C., Gillison M. i wsp.: Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J. Clin. Oncol. 32, 3365–3373 (2014)

19. Feller L., Lemmer J.: Oral leukoplakia as it relates to HPV infection: a review. Int. J. Dent. DOI:10.1155/2012/540561 (2012)

20. Giroglou T., Florin L., Schäfer F., Streeck R. E., Sapp M.: Human papillomavirus infection requires cell surface heparan sulfate, J. Virol. 75, 1565–1570 (2001)

21. Gissmann L., Diehl V., Schultz-Coulon H.J., Zur Hausen H.: Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J. Virol. 44, 393–400 (1982)

22. Griego A.M., Ozbun M.A., Barraza P.F., Hu C., Dziduszko A., Crawley B.K., Hathaway H.J., Bauman J.E.: Cetuximab Has Antiviral Activities in Human Papillomavirus (HPV) – Infected Cells and HPV – Associated Tumors. Int. J. Radiat. Oncol. Biol. Phys. 94, 937–938 (2016)

23. Guan X., Sturgis E. M., Lei D., Liu Z., Dahlstrom K.R., Wei Q., Li G.: Association of TGF-β1 genetic variants with HPV16-positive oropharyngeal cancer. Clinical Cancer Research, 16, 1416–1422 (2010)

24. Hirnle L.: Przypadek infekcji wirusem HPV kobiety oraz jej dziecka urodzonego drogą cięcia cesarskiego. Przypadki medyczne.pl, 36, 149–153 (2013)

25. https://talk.ictvonline.org/ictv-reports/ictv_9th_report/dsdna-viruses-2011/w/dsdna_viruses/121/papillomaviridae [23-03-2017]

26. Human papillomavirus vaccines: WHO position paper, October 2014, Wkly Epidemiol. Rec. WHO, 89, 465–492 (2014)

27. Jurkiewicz D., Dżaman K., Rapiejko P.: Czynniki ryzyka raka krtani. Pol. Merk. Lek. 121, 94–98 (2006)

28. Kashima H., Leventhal B., Mounts P., Hruban R.H. Sites of predilection in recurrent respiratory papillomatosis, Ann. Otol. Rhinol. Laryngol. 102, 580–583 (1993)

29. Kiwerska K., Mielcarek-Kuchta D., Jarmuż-Szymczak M., Szyfter K.: Infekcja HPV jako alternatywna wobec palenia tytoniu droga rozwoju nowotworów głowy i szyi – jakie ma znaczenie dla pacjenta? Przegl. Lek. 69, 1074–178 (2012)

30. Koparal M., Alan H., Gunduz D.T., Gulsun B., Unsal H.Y., Erdogdu H.I.: Human papilloma virus. Journal of Turgut Ozal Medical Center, 23, 353–356 (2016)

31. Lagatie O., Tritsmans L., Stuyver L.J.: The miRNA world of polyomaviruses. Virology, 10, 268 (2013)

32. Liu T., Wentland C., Greenberg M., Sepe B., Huynh T., Kodack D., Mino-Kenudson M., Benes C., Hartnick C., Engelman J.: Detection of PD-L1 and lymphocytes infiltration in Juvenile Recurrent Respiratory Papillomatosis (JRRP). Cancer Immunology Research, 5, DOI: 10.1158/2326-6074 (2017)

33. Louvanto K., Sarkola M., Rintala M., Syrjänen K., Grenman S., Syrjänen S.: Breast milk is a potential vehicle for HPV transmission to oral mucosa of the spouse. Pediat. Infect. Dis. J. DOI: 10.1097/INF.0000000000001546 (2017)

34. Majewski S., Pniewski T., Goyal-Stec M.: Rola wirusów brodawczaka w rozwoju zmian łagodnych i złośliwych okolicy narządów płciowych. Zakażenia, 6, 58–62 (2005)

35. Mohr M., Berdel W. E. i wsp.: Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. Oncol. Lett. 8, 1912–1918 (2014)

36. Mondini M., Deutsch E. i wsp.: Synergy of radiotherapy and a cancer vaccine for the treatment of HPV-associated head and neck cancer. Mol. Cancer Ther. 14, 1336–1345 (2015)

37. Morshed K.: Udział wirusa brodawczaka ludzkiego (HPV) w etiopatogenezie nowotworów głowy i szyi. Otolaryngol. 3, 91–96 (2004)

38. Munro A., Cruickshank M.E. i wsp.: The impact of HPV type on colposcopy performance in women offered HPV immunisation in a catch‐up vaccine programme: a two centre observational study. BJOG, DOI: 10.1111/1471-0528.14563 (2017)

39. Nowaczewska K., Wójtowicz P., Kukwa A., Ratajczak J., Tulibacki M.: Brodawczaki górnych dróg oddechowych – nowe metody leczenia. Otolaryngol. Pol. 64, 31–36 (2010)

40. Parfenov M., Kucherlapati R. i wsp.: Characterization of HPV and host genome interactions in primary head and neck cancers. P. Natl. Acad. Sci. USA, 111, 15544–15549, (2014)

41. Petito G., dos Santos Carneiro M.A., de Rabello Santos S.H., Silva A.M.T.C., de Cassia Alencar R., Gontijo A.P., Saddi V.A.: Human papillomavirus in oral cavity and oropharynx carcinomas in the central region of Brazil. Braz. J. Otorhinolaryngol. 83, 38–44 (2016)

42. Petkowicz B., Skiba M., Tomaszewski T., Wysokińska-Miszczuk J.: Leukoplakia błony śluzowej jamy ustnej w aspekcie klinicznym i epidemiologicznym – analiza przypadków. Dent. Med. Probl. 41, 635–641 (2004)

43. Petrosky E., Bocchini Jr J.A., Hariri S., Chesson H., Curtis C.R., Saraiya M., Unger E.R., Markowitz L.E.: Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb. Mortal. Wkly. Rep. 64, 300–304. (2015)

44. Piłat P., Borzęcki A., Krasowska D.: Rozległa choroba Bowena twarzy – leczenie skojarzone. Przegl. Dermatol. 101, 201–204 (2014)

45. Rutkowski T., Składowski K.: Wpływ wirusa brodawczaka ludzkiego (HPV) na powstanie, przebieg i skuteczność leczenia raków regionu głowy i szyi. Współcz. Onkol. 13, 233–240 (2009)

46. Sabeena S., Pallade S.R., Kamath N., Mathew M., Arunkumar G.: Papilloma of lip associated with human papilloma viruses-32 infection in a child. Indian J. Med. Microbiol. 34, 97 (2016)

47. Santarelli G.D., Derkay, C.S.: HPV vaccines for treatment and prevention of recurrent respiratory papillomatosis. Current Otorhinolaryngology Reports, 4, 85–89 (2016)

48. Schiffman M., Castle P.E.: Human papillomavirus: epidemiology and public health. Arch. Pathol. Lab. Med. 127, 930–934 (2003)

49. Schiller J.T., Day P.M., Kines R.C.: Current understanding of the mechanism of HPV infection. Gynecol. Oncol. 118, 12–17 (2010)

50. Sinal S.H., Woods C.R.: Human papillomavirus infections of the genital and respiratory tracts in young children. Semin. Pediatr. Infect. Dis. 16, 306–316 (2005)

51. Smith E.M., Ritchie J.M., Summersgill K.F., Klussmann J.P., Lee J. H., Wang D., Haugen T.H., Turek L.P.: Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int. J. Cancer, 108, 766–772 (2004)

52. Smith E.M., Summersgill K.F., McCulloch T., Allen J., Turek L.P., Hoffman H.T., Haugen T.H.: Human papillomavirus and risk of laryngeal cancer. Ann. Otol. Rhinol. Laryngol. 109, 1069–1076 (2000)

53. Stich M., Ganss L., Puschhof J., Prigge E.S., Reuschenbach M., Guiterrez A., Vinokurova S., von Knebel Doeberitz M.: 5-aza-2’-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells. Oncotarget, DOI: 10.18632/oncotarget.10631 (2016)

54. Symer D.E., Akagi K., Coombes K.R., Xiao W., Pickard R.K., Agrawal A., Gillison M.L.: Comprehensive genomic analysis of human papillomavirus-associated oral cancers. AACR, DOI: 10.1158/1538-7445 (2016)

55. Szczerba-Turek A., Szweda W., Siemionek J., Platt-Samoraj A., Bancerz-Kisiel A., Teodorowski P.: Molekularne mechanizmy nowotworzenia Papillomaviridae u zwierząt i ludzi. Med. Wet. 63, 1045–1048 (2007)

56. Tay S.K., Ho T.H., Lim-Tan S.K.: Is genital human papillomavirus infection always sexually transmitted?, Aust. N.Z.J. of Obstet. Gynaecol. 30, 240–242 (1990)

57. Van Doorslaer K.: Evolution of the papillomaviridae. Virology, 445, 11–20 (2013)

58. Vermorken J.B., Psyrri A., Mesia R., Peyrade F., Beie F., De Blas B., Celik I., Licitra L.: Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial. Ann. Oncol. 25, 801–807 (2014)

59. ViralZone.expasy.org/ Betapapillomavirus [23-03-2017]

60. ViralZone.expasy.org/ Epsilonpapillomavirus [23-03-2017]

61. ViralZone.expasy.org/Gammapapillomavirus [23-03-2017]

62. ViralZone.expasy.org/Lambdapapillomavirus [23-03-2017]

63. ViralZone.expasy.org/Mupapillomavirus [23-03-2017]

64. ViralZone.expasy.org/Nupapillomavirus [23-03-2017]

65. Wardak S.: Wirus brodawczaka ludzkiego (Human Papilloma Virus-HPV) a rak szyjki macicy. Human Papillomavirus (HPV) and cervical cancer. Med. Dośw. Mikrobiol. 68, 73–84 (2016)

66. Westra W.H.: The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol. 3, 78 (2009)

67. World Health Organization: Who.int/ Human papillomavirus and cervical cancer [23-03-2017]

68. Wiciński M., Malinowski B., Grześk E., Szadujkis-Szadurska K., Czeczuk A., Michalska A., Klonowska J., Wójtowicz-Chomicz K., Ostrowska J., Stolarek W., Grześk G.: Czynniki biologiczne w etiopatogenezie schizofrenii. Post. Mikrobiol. 53, 328–334 (2014)

69. Wiciński M., Sopońska P. Brzoszczyk B., Malinowski B., Michalska A., Grześk E., Szadujkis-Szadurska K., Kornatowski T., Czeczuk A., Grześk G.: Udział ludzkiego cytomegalowirusa w mechanizmach karcynogenezy glejaka wielopostaciowego. Post. Mikrobiol. 52, 355–361 (2013)

70. Wiciński M., Sopońska P., Brzoszczyk B., Malinowski B., Grześk E., Michalska A.: Rola czynników zakaźnych w chorobach neurodegeneracyjnych. Post. Mikrobiol. 52, 93–103 (2013)

71. Yıldırım F., Türk M., Demircan S., Akyürek N., Yurdakul A.S.: Tracheal papilloma treated with cryotherapy and interferon-α: a case report and review of the literature. Case Rep. Pulmonol. DOI: 10.1155/2015/356796 (2015)

72. Zheng Z.M., Baker C.C.: Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 11, 2286 (2006)

EXTRA FILES

COMMENTS